Non-alcoholic steatohepatitis in children
- PMID: 15598336
- DOI: 10.1111/j.1399-3046.2004.00241.x
Non-alcoholic steatohepatitis in children
Abstract
Obesity has emerged as a significant new health problem in the pediatric population. Non-alcoholic steatohepatitis (NASH) is an entity in the spectrum of non-alcoholic fatty liver disease (NAFLD) ranges from fat in the liver -- simple steatosis, NASH/ steatohepatitis -- fat with inflammation and/or fibrosis to advanced fibrosis and cirrhosis when fat may no longer be present. NASH is associated with obesity, diabetes, insulin resistance (IR), and hypertriglyceridemia. While majority of individuals with risk factors like obesity and IR have steatosis only a minority develop steatohepatitis, possible mechanisms have been discussed. Clinical experience with pediatric NASH is limited. Children generally present in the prepubertal age group, have a male predominance with a higher incidence in children of Hispanic origin. Body mass index (BMI) of 25-29.9 is considered to be overweight and that > or =30 obese. Acanthosis nigricans as a marker of IR should be looked for. As NASH is a diagnosis of exclusion, other causes of chronic liver disease must be excluded. Increased echogenicity in the liver is noted on ultrasound. Liver biopsy is considered the gold standard in establishing the diagnosis. Histopathological lesions thought to be necessary for diagnosis of NASH include steatosis (macrovesicular > microvesicular), mixed mild lobular inflammation and hepatocyte ballooning. A system of grading depending on degree of steatosis and/or inflammation and staging depending on the extent of fibrosis has also been proposed. Although there is no consensus for the treatment for NASH, effort needs to be made to prevent development of fibrosis, which results in cirrhosis and portal hypertension. Slow, consistent weight loss has been shown to be effective in childhood NAFLD, based on improvement of serum aminotransferases or liver sonogram. A low glycemic index diet has been shown to be more effective than a low fat diet in lowering BMI. Family based behavioral intervention may also enhance success with diet. Several pharmacological agents have been used including ursodeoxycholic acid, vitamin E, betaine, n-acetyl cysteine, and insulin sensitizing agents like metformin, rosiglitazone, and pioglitazone. Transplantation for overt NASH is rare, accounting for < 1% of liver transplantations in the USA. The disease can recur after liver transplantation. A strong association exists between the presence of steatosis in a donor liver and poor graft function. As a result, cadaveric donor livers with macrovesicular steatosis >40% are not used routinely. Prognosis in NASH is dependent not only on severity and number of risk factors but also on the degree of histological damage. Clinical trials are needed to identify an effective treatment that halts the progression of NAFLD to NASH in both pretransplantation and post-transplantation patients.
Similar articles
-
Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.Obes Surg. 2006 Dec;16(12):1584-93. doi: 10.1381/096089206779319392. Obes Surg. 2006. PMID: 17217634
-
[Non-alcoholic fatty liver disease--new view].Pol Merkur Lekarski. 2008 Jun;24(144):568-71. Pol Merkur Lekarski. 2008. PMID: 18702346 Review. Polish.
-
Nonalcoholic fatty liver disease.Rev Gastroenterol Disord. 2002;2(1):11-9. Rev Gastroenterol Disord. 2002. PMID: 12122975 Review.
-
[Nonalcoholic steatohepatitis--a "new" hepatic disease].Ugeskr Laeger. 2003 Mar 10;165(11):1115-8. Ugeskr Laeger. 2003. PMID: 12677985 Review. Danish.
-
[Non-alcoholic fatty liver].Rev Gastroenterol Peru. 2003 Jan-Mar;23(1):49-57. Rev Gastroenterol Peru. 2003. PMID: 12768215 Review. Spanish.
Cited by
-
Prevalence of non-alcoholic fatty liver disease in overweight and obese children seeking ambulatory healthcare in Nairobi, Kenya.BMJ Open Gastroenterol. 2023 Feb;10(1):e001044. doi: 10.1136/bmjgast-2022-001044. BMJ Open Gastroenterol. 2023. PMID: 36796875 Free PMC article.
-
Effects of probiotics combined with dietary and lifestyle modification on clinical, biochemical, and radiological parameters in obese children with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: a randomized clinical trial.Clin Exp Pediatr. 2022 Jun;65(6):304-311. doi: 10.3345/cep.2021.00787. Epub 2021 Nov 11. Clin Exp Pediatr. 2022. PMID: 34773939 Free PMC article.
-
Metabolic Abnormalities in a Cohort of Overweight and Obese Children in an Urban Setting of Sri Lanka.Int J Endocrinol. 2021 Jul 5;2021:9936889. doi: 10.1155/2021/9936889. eCollection 2021. Int J Endocrinol. 2021. PMID: 34285694 Free PMC article.
-
Dental Caries and Its Association with Body Mass Index among School Children of Riyadh, Saudi Arabia.J Pharm Bioallied Sci. 2020 Aug;12(Suppl 1):S176-S181. doi: 10.4103/jpbs.JPBS_53_20. Epub 2020 Aug 28. J Pharm Bioallied Sci. 2020. PMID: 33149452 Free PMC article.
-
A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.Int J Mol Sci. 2016 Jun 15;17(6):947. doi: 10.3390/ijms17060947. Int J Mol Sci. 2016. PMID: 27314342 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials